olysio (Gilead Sciences)
97
Structured Review
Gilead Sciences
olysio
Olysio, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 890 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olysio/Sovaldi/us12409249-781-109-110
Average 97 stars, based on 890 article reviews
Olysio, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 890 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olysio/Sovaldi/us12409249-781-109-110
Average 97 stars, based on 890 article reviews
olysio - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
other:Article Title: Clinical Characteristics and Patterns of Care Among Patients With Genotype 1 (G1) Hepatitis C Virus In Europe (Eu) Article Snippet: Results: Victrelis®, Daklinza®, Roferon A®, Intron A®, Harvoni®, Viekirax®, Pegasys RBV®, PegIntron®, Rebetol®, Olysio®, Sovaldi®, and Incivo® were the pharmacotherapies for which manufacturer submissions were available across selected agencies. Activation Assay:Article Title: Compositions and methods for immune tolerance Article Snippet: .. The cell mixtures, cell aggregates and implantable grafts disclosed herein can be administered in combination with one or more additional immunosuppressive therapies including, but not limited to drugs which inhibit T-cell activation (e.g., calcineurin (CaN) inhibitors), systemic immunosuppressants for universal transplant immunotolerance (corticosteroids such as methylprednisolone (Medrol), prednisone or prednisolone), CNI such as tacrolimus (Prograf, Astafraf), cyclosporine (Neoral, Sandimmune, Gengraf), anti-metabolites such as Mycophenolate motefil (Cellcept, Myfortic), Azathioprine (Imuran), mTORI such as Sirolimus (Rapamune), Everolimus (Afinitor), T-cell depleting monoclonal antibodies such as muromonab-CD3 (OKT3), Alemtuzumab (Campath-1H), ATG (Thymoblobulin, ATGAM), IL-2-Ra monoclonal antibodies such as daclizumab (Zenapax), Basiliximab (Simulect), N-Acetyl Cysteine (NAC), Heplisav-B, Mavyret, Vosevi, Ocaliva, Zepatier, Cholbam, Daklinza, Technivie, Bioprocessing:Article Title: Compositions and methods for immune tolerance Article Snippet: .. The cell mixtures, cell aggregates and implantable grafts disclosed herein can be administered in combination with one or more additional immunosuppressive therapies including, but not limited to drugs which inhibit T-cell activation (e.g., calcineurin (CaN) inhibitors), systemic immunosuppressants for universal transplant immunotolerance (corticosteroids such as methylprednisolone (Medrol), prednisone or prednisolone), CNI such as tacrolimus (Prograf, Astafraf), cyclosporine (Neoral, Sandimmune, Gengraf), anti-metabolites such as Mycophenolate motefil (Cellcept, Myfortic), Azathioprine (Imuran), mTORI such as Sirolimus (Rapamune), Everolimus (Afinitor), T-cell depleting monoclonal antibodies such as muromonab-CD3 (OKT3), Alemtuzumab (Campath-1H), ATG (Thymoblobulin, ATGAM), IL-2-Ra monoclonal antibodies such as daclizumab (Zenapax), Basiliximab (Simulect), N-Acetyl Cysteine (NAC), Heplisav-B, Mavyret, Vosevi, Ocaliva, Zepatier, Cholbam, Daklinza, Technivie, |
